Stocks:
5,167
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.23T
24h Vol:
$10.73B
Dominance:
MSFT:4.87%
Stocklytics Platform
Instrument logo  TXMD
TherapeuticsMD
TXMD
39 / 100
Penny Stock
$1.88arrow_drop_up0.39%$0.00

Performance History

Stocklytics logo
Key Stats
Open$1.89
Prev. Close$1.88
EPS-0.74
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap21680912.00
PE Ratio-
LOWHIGH
Day Range1.87
1.89
52 Week Range1.86
4.72
Ratios
P/B Ratio0.78
Revenue$1.30M
Operating M. %-320.92%
Earnings$0.00
Earnings Growth %-816.85%
EBITDA Margin %-645.24%
ROE %-23.90%
EPS-0.74

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

39vs 56. Market Avg.

All Score 39 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

TXMDMARKET
Value6040
Quality2740
Ownership1417
Growth2445
Dividends-38
check_circle

TherapeuticsMD 's Price discount from all time high of 99.98% is great compared to market average of 41.98%. This indicates TXMD could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$731.42
24H (%)arrow_drop_down1.91%
24H ($)-$14.27
MARKET CAP$695.32B
PRICE$482.23
24H (%)arrow_drop_down0.81%
24H ($)-$3.94
MARKET CAP$452.88B
PRICE$147.47
24H (%)arrow_drop_down1.39%
24H ($)-$2.09
MARKET CAP$359.34B
PRICE$126.00
24H (%)arrow_drop_down0.69%
24H ($)-$0.88
MARKET CAP$321.39B

About TherapeuticsMD (TXMD)

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
-
Headquarters
Boca Raton
Employees
1
Exchange
NASDAQ
add TherapeuticsMD  to watchlist

Keep an eye on TherapeuticsMD

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the market capitalization of TherapeuticsMD (TXMD)?

TherapeuticsMD (TXMD) has a market capitalization of $21.68M. The average daily trading volume is 22.89K, indicating the stock's liquidity and investor engagement.

help
What is TherapeuticsMD 's (TXMD) price per share?

The current price per share for TherapeuticsMD (TXMD) is $1.89. The stock has seen a price change of $0.01 recently, indicating a 0.39% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for TherapeuticsMD (TXMD)?

For TherapeuticsMD (TXMD), the 52-week high is $4.72, which is 150.08% from the current price. The 52-week low is $1.86, the current price is 1.47% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is TherapeuticsMD (TXMD) a growth stock?

TherapeuticsMD (TXMD) has shown an average price growth of -66.16% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying TherapeuticsMD as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is TherapeuticsMD (TXMD) stock price performance year to date (YTD)?

As of the latest data, TherapeuticsMD (TXMD) has a year-to-date price change of -19%. Over the past month, the stock has experienced a price change of -15.74%. Over the last three months, the change has been -17.58%. Over the past six months, the figure is -12.62%.

help
Is TherapeuticsMD (TXMD) a profitable company?

TherapeuticsMD (TXMD) has a net income of -$7.7M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 29.19% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -320.92% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.3M, although specific revenue growth data is currently not available. The gross profit is $380K. Operating income is noted at -$8.52M. Furthermore, the EBITDA is $21.33M.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.